Fasting clinical trials

Explore recruiting fasting clinical trials.

Recruiting fasting studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fasting trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Dasatinib and quercetin, a combination of senolytics to treat fibrotic non-alcoholic fatty liver disease; The TRUTH study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with Partial Lipodystrophy

Spain, Netherlands, Belgium, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pharmacokinetics of Nicorandil 40 mg Extended-Release Capsules: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting and Fed Conditions.

Portugal

Human Pharmacology (Phase I)- Other EU CTIS Study details

An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia (SHTG)

Bulgaria, Hungary, Poland, France, Spain, Czechia +13 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 12 mg film-coated tablets versus reference product Fycompa 12 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Familial Chylomicronemia Syndrome

Ireland, France, Spain, Belgium, Croatia, Poland +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fasting trials by city

Fasting in Toronto Fasting in Vancouver Fasting in Montreal Fasting in Calgary Fasting in Edmonton Fasting in Ottawa Fasting in Winnipeg Fasting in Quebec City Fasting in Hamilton Fasting in Kitchener Fasting in London Fasting in Halifax Fasting in New York Fasting in Los Angeles Fasting in Chicago Fasting in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease